$AEGR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aegerion Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aegerion Pharmaceuticals, Inc.. Get notifications about new insider transactions in Aegerion Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 09 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Sell | S | 16.90 | 1,002 | 16,929 | 1,062,306 | 1.1 M to 1.1 M (-0.09 %) | |
Dec 09 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Sell | S | 16.89 | 17,567 | 296,717 | 2,603,834 | 2.6 M to 2.6 M (-0.67 %) | |
Dec 09 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Sell | S | 16.90 | 2,472 | 41,765 | 2,621,401 | 2.6 M to 2.6 M (-0.09 %) | |
Dec 09 2011 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Sell | S | 16.89 | 17,567 | 296,717 | 2,603,834 | 2.6 M to 2.6 M (-0.67 %) | |
Dec 09 2011 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Sell | S | 16.90 | 2,472 | 41,765 | 2,621,401 | 2.6 M to 2.6 M (-0.09 %) | |
Dec 09 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Sell | S | 16.89 | 17,763 | 300,028 | 2,632,879 | 2.7 M to 2.6 M (-0.67 %) | |
Dec 09 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Sell | S | 16.90 | 2,500 | 42,238 | 2,650,642 | 2.7 M to 2.7 M (-0.09 %) | |
Dec 08 2011 | AEGR | Aegerion Pharmaceu ... | Advent Partners HLS III Limite ... | Sell | S | 16.96 | 61 | 1,034 | 29,269 | 29.3 K to 29.3 K (-0.21 %) | |
Dec 08 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Sell | S | 16.96 | 2,230 | 37,816 | 1,063,308 | 1.1 M to 1.1 M (-0.21 %) | |
Dec 08 2011 | AEGR | Aegerion Pharmaceu ... | Advent Healthcare & Life Scien ... | Sell | S | 16.96 | 3,274 | 55,520 | 1,560,565 | 1.6 M to 1.6 M (-0.21 %) | |
Dec 08 2011 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Sell | S | 16.96 | 5,504 | 93,337 | 2,623,873 | 2.6 M to 2.6 M (-0.21 %) | |
Dec 08 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Sell | S | 16.96 | 5,504 | 93,337 | 2,623,873 | 2.6 M to 2.6 M (-0.21 %) | |
Dec 08 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Sell | S | 16.96 | 5,565 | 94,371 | 2,653,142 | 2.7 M to 2.7 M (-0.21 %) | |
Nov 08 2011 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Option Exercise | A | 13.01 | 180,000 | 2,341,800 | 180,000 | |
Nov 08 2011 | AEGR | Aegerion Pharmaceu ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | A | 13.01 | 30,000 | 390,300 | 30,000 | |
Sep 06 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 14.76 | 1,484 | 21,904 | 7,156 | 5.7 K to 7.2 K (+26.16 %) |
Sep 06 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 14.75 | 5,270 | 77,733 | 197,061 | 191.8 K to 197.1 K (+2.75 %) |
Aug 10 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 11.91 | 1,800 | 21,438 | 133,147 | 131.3 K to 133.1 K (+1.37 %) |
Aug 10 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 11.96 | 8,265 | 98,849 | 131,347 | 123.1 K to 131.3 K (+6.72 %) |
Aug 09 2011 | AEGR | Aegerion Pharmaceu ... | Kiley Alison | Director | Buy | P | 12.45 | 5,500 | 68,497 | 2,690,251 | 2.7 M to 2.7 M (+0.20 %) |
Aug 09 2011 | AEGR | Aegerion Pharmaceu ... | Kiley Alison | Director | Buy | P | 12.43 | 4,200 | 52,204 | 2,684,751 | 2.7 M to 2.7 M (+0.16 %) |
Aug 09 2011 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | P | 12.45 | 124 | 1,544 | 60,721 | 60.6 K to 60.7 K (+0.20 %) |
Aug 09 2011 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | P | 12.43 | 95 | 1,181 | 60,597 | 60.5 K to 60.6 K (+0.16 %) |
Aug 09 2011 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | P | 12.45 | 338 | 4,209 | 165,478 | 165.1 K to 165.5 K (+0.20 %) |
Aug 09 2011 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | P | 12.43 | 258 | 3,207 | 165,140 | 164.9 K to 165.1 K (+0.16 %) |
Aug 09 2011 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | P | 12.45 | 5,038 | 62,743 | 2,464,052 | 2.5 M to 2.5 M (+0.20 %) |
Aug 09 2011 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | P | 12.43 | 3,847 | 47,817 | 2,459,014 | 2.5 M to 2.5 M (+0.16 %) |
Aug 03 2011 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | A | 15.26 | 23,521 | 358,930 | 23,521 | |
Aug 03 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 15.74 | 1,392 | 21,910 | 123,082 | 121.7 K to 123.1 K (+1.14 %) |
Aug 03 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 15.74 | 4,938 | 77,724 | 121,690 | 116.8 K to 121.7 K (+4.23 %) |
Aug 02 2011 | AEGR | Aegerion Pharmaceu ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 14.61 | 36,788 | 537,425 | 2,131,827 | 2.2 M to 2.1 M (-1.70 %) |
Aug 02 2011 | AEGR | Aegerion Pharmaceu ... | Ollier Michele | Director | Sell | S | 14.61 | 36,788 | 537,425 | 2,131,827 | 2.2 M to 2.1 M (-1.70 %) |
Jul 29 2011 | AEGR | Aegerion Pharmaceu ... | Advent Healthcare & Life Scien ... | Sell | S | 14.61 | 3,015 | 44,045 | 1,563,839 | 1.6 M to 1.6 M (-0.19 %) | |
Jul 29 2011 | AEGR | Aegerion Pharmaceu ... | Advent Partners HLS III Limite ... | Sell | S | 14.61 | 57 | 833 | 29,330 | 29.4 K to 29.3 K (-0.19 %) | |
Jul 29 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Sell | S | 14.61 | 2,054 | 30,006 | 1,065,538 | 1.1 M to 1.1 M (-0.19 %) | |
Jul 29 2011 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Sell | S | 14.61 | 5,069 | 74,052 | 2,629,377 | 2.6 M to 2.6 M (-0.19 %) | |
Jul 29 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Sell | S | 14.61 | 5,069 | 74,052 | 2,629,377 | 2.6 M to 2.6 M (-0.19 %) | |
Jul 29 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Sell | S | 14.61 | 5,126 | 74,884 | 2,658,707 | 2.7 M to 2.7 M (-0.19 %) | |
Jul 01 2011 | AEGR | Aegerion Pharmaceu ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 14.61 | 877,723 | 12,822,392 | 2,168,435 | 3 M to 2.2 M (-28.81 %) |
Jul 01 2011 | AEGR | Aegerion Pharmaceu ... | Ollier Michele | Director | Sell | S | 14.61 | 877,723 | 12,822,392 | 2,168,435 | 3 M to 2.2 M (-28.81 %) |
Jun 29 2011 | AEGR | Aegerion Pharmaceu ... | Advent Partners HLS III Limite ... | Sell | S | 14.61 | 1,349 | 19,707 | 29,387 | 30.7 K to 29.4 K (-4.39 %) | |
Jun 29 2011 | AEGR | Aegerion Pharmaceu ... | Advent Healthcare & Life Scien ... | Sell | S | 14.61 | 71,923 | 1,050,702 | 1,566,854 | 1.6 M to 1.6 M (-4.39 %) | |
Jun 29 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Sell | S | 14.61 | 49,005 | 715,899 | 1,067,592 | 1.1 M to 1.1 M (-4.39 %) | |
Jun 29 2011 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Sell | S | 14.61 | 120,928 | 1,766,601 | 2,634,446 | 2.8 M to 2.6 M (-4.39 %) | |
Jun 29 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Sell | S | 14.61 | 120,928 | 1,766,601 | 2,634,446 | 2.8 M to 2.6 M (-4.39 %) | |
Jun 29 2011 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Sell | S | 14.61 | 122,277 | 1,786,308 | 2,663,833 | 2.8 M to 2.7 M (-4.39 %) | |
Jun 29 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Sell | P | 15.50 | 64,516 | 999,998 | 181,268 | 245.8 K to 181.3 K (-26.25 %) |
Jun 03 2011 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | A | 17.64 | 9,988 | 176,188 | 29,915 | |
Jun 03 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Option Exercise | A | 17.64 | 115,000 | 2,028,600 | 1,000,653 | |
Jun 03 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 18.73 | 1,170 | 21,914 | 116,752 | 115.6 K to 116.8 K (+1.01 %) |
Jun 03 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 18.69 | 4,162 | 77,788 | 115,582 | 111.4 K to 115.6 K (+3.74 %) |
Jun 03 2011 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | A | 17.64 | 9,988 | 176,188 | 20,226 | |
Jun 03 2011 | AEGR | Aegerion Pharmaceu ... | Kiley Alison | Director | Option Exercise | A | 17.64 | 9,988 | 176,188 | 9,988 | |
Jun 03 2011 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | A | 17.64 | 9,988 | 176,188 | 9,988 | |
Jun 03 2011 | AEGR | Aegerion Pharmaceu ... | Ollier Michele | Director | Option Exercise | A | 17.64 | 9,988 | 176,188 | 9,988 | |
Jun 03 2011 | AEGR | Aegerion Pharmaceu ... | Fitzpatrick Mark J. | Chief Financial Off ... | Option Exercise | A | 17.64 | 220,000 | 3,880,800 | 220,000 | |
May 09 2011 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | A | 19.25 | 19,927 | 383,595 | 19,927 | |
May 09 2011 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Grant | A | 0.00 | 29,890 | 0 | 29,890 | 0 to 29.9 K |
Apr 05 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 16.73 | 1,310 | 21,916 | 111,420 | 110.1 K to 111.4 K (+1.19 %) |
Apr 05 2011 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 16.73 | 4,647 | 77,744 | 110,110 | 105.5 K to 110.1 K (+4.41 %) |
Mar 14 2011 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Buy | P | 15.36 | 6,006 | 92,252 | 650,154 | 644.1 K to 650.2 K (+0.93 %) |
Mar 14 2011 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Buy | P | 15.11 | 3,994 | 60,349 | 644,148 | 640.2 K to 644.1 K (+0.62 %) |
Mar 02 2011 | AEGR | Aegerion Pharmaceu ... | Tribble Diane L. | Chief Scientific Of ... | Option Exercise | A | 14.84 | 220,000 | 3,264,800 | 220,000 | |
Mar 02 2011 | AEGR | Aegerion Pharmaceu ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | A | 14.84 | 132,000 | 1,958,880 | 132,000 | |
Dec 17 2010 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 12.33 | 200 | 2,465 | 105,463 | 105.3 K to 105.5 K (+0.19 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | C | 0.00 | 15,327 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | C | 0.00 | 41,768 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | C | 0.00 | 621,923 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | C | 0.00 | 69,176 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | C | 0.00 | 188,514 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | C | 0.00 | 2,806,991 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | P | 9.50 | 7,128 | 67,716 | 60,502 | 53.4 K to 60.5 K (+13.35 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | C | 7.60 | 17,250 | 131,100 | 53,374 | 36.1 K to 53.4 K (+47.75 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | C | 0.00 | 9,353 | 0 | 36,124 | 26.8 K to 36.1 K (+34.94 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | C | 0.00 | 26,771 | 0 | 26,771 | 0 to 26.8 K |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | P | 9.50 | 19,425 | 184,538 | 164,882 | 145.5 K to 164.9 K (+13.35 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | C | 7.60 | 47,010 | 357,276 | 145,457 | 98.4 K to 145.5 K (+47.75 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | C | 0.00 | 25,490 | 0 | 98,447 | 73 K to 98.4 K (+34.94 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | C | 0.00 | 72,957 | 0 | 72,957 | 0 to 73 K |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | P | 9.50 | 289,236 | 2,747,742 | 2,455,167 | 2.2 M to 2.5 M (+13.35 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | C | 7.60 | 700,050 | 5,320,380 | 2,165,931 | 1.5 M to 2.2 M (+47.76 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | C | 0.00 | 379,545 | 0 | 1,465,881 | 1.1 M to 1.5 M (+34.94 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Buy | C | 0.00 | 1,086,336 | 0 | 1,086,336 | 0 to 1.1 M |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | FISHERMAN JASON S | Director | Option Exercise | C | 0.00 | 2,041 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | FISHERMAN JASON S | Director | Option Exercise | C | 0.00 | 9,212 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | FISHERMAN JASON S | Director | Buy | P | 9.50 | 739 | 7,021 | 7,848 | 7.1 K to 7.8 K (+10.40 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | FISHERMAN JASON S | Director | Buy | C | 7.60 | 2,286 | 17,374 | 7,109 | 4.8 K to 7.1 K (+47.40 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | FISHERMAN JASON S | Director | Buy | C | 0.00 | 1,245 | 0 | 4,823 | 3.6 K to 4.8 K (+34.80 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | FISHERMAN JASON S | Director | Buy | C | 0.00 | 3,565 | 0 | 3,578 | 13 to 3.6 K (+27,423.08 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Partners HLS III Limite ... | Option Exercise | C | 0.00 | 7,994 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Partners HLS III Limite ... | Option Exercise | C | 0.00 | 36,079 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Partners HLS III Limite ... | Buy | P | 9.50 | 2,895 | 27,503 | 30,736 | 27.8 K to 30.7 K (+10.40 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Partners HLS III Limite ... | Buy | C | 7.60 | 8,952 | 68,035 | 27,841 | 18.9 K to 27.8 K (+47.39 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Partners HLS III Limite ... | Buy | C | 0.00 | 4,878 | 0 | 18,889 | 14 K to 18.9 K (+34.82 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Partners HLS III Limite ... | Buy | C | 0.00 | 13,962 | 0 | 14,011 | 49 to 14 K (+28,493.88 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Healthcare & Life Scien ... | Option Exercise | C | 0.00 | 425,403 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Healthcare & Life Scien ... | Option Exercise | C | 0.00 | 1,920,018 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Healthcare & Life Scien ... | Buy | P | 9.50 | 154,790 | 1,470,505 | 1,638,777 | 1.5 M to 1.6 M (+10.43 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Healthcare & Life Scien ... | Buy | C | 7.60 | 478,852 | 3,639,275 | 1,483,987 | 1 M to 1.5 M (+47.64 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Healthcare & Life Scien ... | Buy | C | 0.00 | 259,613 | 0 | 1,005,135 | 745.5 K to 1 M (+34.82 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Advent Healthcare & Life Scien ... | Buy | C | 0.00 | 743,068 | 0 | 745,522 | 2.5 K to 745.5 K (+30,279.87 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Option Exercise | C | 0.00 | 289,844 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Option Exercise | C | 0.00 | 1,308,186 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Buy | P | 9.50 | 105,473 | 1,001,994 | 1,116,597 | 1 M to 1.1 M (+10.43 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Buy | C | 7.60 | 326,288 | 2,479,789 | 1,011,124 | 684.8 K to 1 M (+47.64 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Buy | C | 0.00 | 176,885 | 0 | 684,836 | 508 K to 684.8 K (+34.82 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT HEALTHCARE & LIFE SCIEN ... | Buy | C | 0.00 | 506,282 | 0 | 507,951 | 1.7 K to 508 K (+30,334.45 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Option Exercise | C | 0.00 | 715,247 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Option Exercise | C | 0.00 | 3,228,204 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Buy | P | 9.50 | 260,263 | 2,472,499 | 2,755,374 | 2.5 M to 2.8 M (+10.43 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Buy | C | 7.60 | 805,140 | 6,119,064 | 2,495,111 | 1.7 M to 2.5 M (+47.64 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Buy | C | 0.00 | 436,498 | 0 | 1,689,971 | 1.3 M to 1.7 M (+34.82 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | AHLS III GP LIMITED PARTNERSHI ... | Buy | C | 0.00 | 1,249,350 | 0 | 1,253,473 | 4.1 K to 1.3 M (+30,301.96 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Option Exercise | C | 0.00 | 715,247 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Option Exercise | C | 0.00 | 3,228,204 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Buy | P | 9.50 | 260,263 | 2,472,499 | 2,755,374 | 2.5 M to 2.8 M (+10.43 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Buy | C | 7.60 | 805,140 | 6,119,064 | 2,495,111 | 1.7 M to 2.5 M (+47.64 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Buy | C | 0.00 | 436,498 | 0 | 1,689,971 | 1.3 M to 1.7 M (+34.82 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL LLC | Buy | C | 0.00 | 1,249,350 | 0 | 1,253,473 | 4.1 K to 1.3 M (+30,301.96 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Option Exercise | C | 0.00 | 723,241 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Option Exercise | C | 0.00 | 3,264,283 | 0 | 0 | ||
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Buy | P | 9.50 | 263,158 | 2,500,001 | 2,786,110 | 2.5 M to 2.8 M (+10.43 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Buy | C | 7.60 | 814,092 | 6,187,099 | 2,522,952 | 1.7 M to 2.5 M (+47.64 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Buy | C | 0.00 | 441,376 | 0 | 1,708,860 | 1.3 M to 1.7 M (+34.82 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | ADVENT INTERNATIONAL CORP/MA | Buy | C | 0.00 | 1,263,312 | 0 | 1,267,484 | 4.2 K to 1.3 M (+30,280.73 %) | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Lewis William | President, PFO and ... | Option Exercise | C | 0.00 | 43,290 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Lewis William | President, PFO and ... | Option Exercise | C | 0.00 | 122,846 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Lewis William | President, PFO and ... | Buy | C | 7.60 | 35,006 | 266,046 | 108,966 | 74 K to 109 K (+47.33 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Lewis William | President, PFO and ... | Buy | C | 0.00 | 26,418 | 0 | 73,960 | 47.5 K to 74 K (+55.57 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Lewis William | President, PFO and ... | Buy | C | 0.00 | 47,542 | 0 | 47,542 | 0 to 47.5 K |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Kiley Alison | Director | Option Exercise | C | 0.00 | 679,018 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Kiley Alison | Director | Option Exercise | C | 0.00 | 3,064,681 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Kiley Alison | Director | Buy | P | 9.50 | 315,789 | 2,999,996 | 2,860,551 | 2.5 M to 2.9 M (+12.41 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Kiley Alison | Director | Buy | C | 7.60 | 764,310 | 5,808,756 | 2,364,762 | 1.6 M to 2.4 M (+47.76 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Kiley Alison | Director | Buy | C | 0.00 | 414,388 | 0 | 1,600,452 | 1.2 M to 1.6 M (+34.94 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Kiley Alison | Director | Buy | C | 0.00 | 1,186,064 | 0 | 1,186,064 | 0 to 1.2 M |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Index Venture Associates III L ... | 10% Owner | Option Exercise | C | 0.00 | 782,801 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Index Venture Associates III L ... | 10% Owner | Option Exercise | C | 0.00 | 3,533,095 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Index Venture Associates III L ... | 10% Owner | Buy | P | 9.50 | 315,789 | 2,999,996 | 3,041,986 | 2.7 M to 3 M (+11.58 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Index Venture Associates III L ... | 10% Owner | Buy | C | 7.60 | 881,128 | 6,696,573 | 2,726,197 | 1.8 M to 2.7 M (+47.76 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Index Venture Associates III L ... | 10% Owner | Buy | C | 0.00 | 477,723 | 0 | 1,845,069 | 1.4 M to 1.8 M (+34.94 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Index Venture Associates III L ... | 10% Owner | Buy | C | 0.00 | 1,367,346 | 0 | 1,367,346 | 0 to 1.4 M |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | A | 9.50 | 10,238 | 97,261 | 10,238 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Ollier Michele | Director | Option Exercise | C | 0.00 | 782,801 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Ollier Michele | Director | Option Exercise | C | 0.00 | 3,533,095 | 0 | 0 | |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Ollier Michele | Director | Buy | P | 9.50 | 315,789 | 2,999,996 | 3,046,158 | 2.7 M to 3 M (+11.57 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Ollier Michele | Director | Buy | C | 7.60 | 881,128 | 6,696,573 | 2,730,369 | 1.8 M to 2.7 M (+47.65 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Ollier Michele | Director | Buy | C | 0.00 | 477,723 | 0 | 1,849,241 | 1.4 M to 1.8 M (+34.83 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Ollier Michele | Director | Buy | C | 0.00 | 1,367,346 | 0 | 1,371,518 | 4.2 K to 1.4 M (+32,774.35 %) |
Oct 27 2010 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Buy | P | 9.50 | 105,263 | 999,999 | 105,263 | 0 to 105.3 K |